Renalytix (RNLX) Short Interest Ratio & Short Volume → The new financial threat that could wipe out millions… (From InvestorPlace) (Ad) Free RNLX Stock Alerts $0.64 -0.05 (-7.24%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Renalytix Short Interest DataCurrent Short Volume673,700 sharesPrevious Short Volume795,200 sharesChange Vs. Previous Month-15.28%Dollar Volume Sold Short$567,659.62Short Interest Ratio / Days to Cover0.4Last Record DateApril 15, 2024Outstanding Shares77,180,000 sharesPercentage of Shares Shorted0.87%Today's Trading Volume214,322 sharesAverage Trading Volume1,442,398 sharesToday's Volume Vs. Average15% Short Selling Renalytix ? Sign up to receive the latest short interest report for Renalytix and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRNLX Short Interest Over TimeRNLX Days to Cover Over TimeRNLX Percentage of Float Shorted Over Time Ad Crypto 101 MediaElon Musk Secret Crypto Plot ExposedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. Renalytix Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024673,700 shares $567,659.62 -15.3%N/A0.4 $0.84 3/31/2024795,200 shares $683,872.00 -11.1%N/A0.4 $0.86 3/15/2024894,600 shares $769,356.00 +78.7%N/A0.5 $0.86 2/29/2024500,600 shares $585,702.00 -60.6%N/A0.3 $1.17 2/15/20241,270,000 shares $997,331.00 +111.0%N/A1 $0.79 1/31/2024601,800 shares $190,650.24 -10.5%N/A2.3 $0.32 Get the Latest News and Ratings for RNLX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Renalytix and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024672,200 shares $215,104.00 +145.3%N/A3.3 $0.32 12/31/2023274,000 shares $106,860.00 +350.7%N/A2.1 $0.39 12/15/202360,800 shares $22,204.16 -68.9%N/A0.5 $0.37 11/30/2023195,500 shares $92,862.50 -11.5%N/A1.9 $0.48 11/15/2023221,000 shares $130,611.00 -36.5%N/A2.3 $0.59 10/31/2023347,800 shares $361,712.00 +65.6%N/A4.4 $1.04 10/15/2023210,000 shares $243,600.00 +32.4%N/A2.7 $1.16 9/30/2023158,600 shares $253,760.00 -69.2%N/A1.7 $1.60 9/15/2023514,700 shares $1.09 million +4.8%N/A0.8 $2.11 8/31/2023491,000 shares $1.42 million +10.2%N/A0.8 $2.90 8/15/2023445,700 shares $1.14 million -3.8%N/A0.7 $2.55 7/31/2023463,400 shares $1.34 million -40.4%N/A0.7 $2.90 7/15/2023777,400 shares $2.92 million +123.2%N/A1.2 $3.76 6/30/2023348,300 shares $1.02 million -6.5%N/A0.6 $2.92 6/15/2023372,400 shares $871,416.00 -3.3%N/A8.1 $2.34 5/31/2023385,200 shares $943,740.00 +44.9%N/A8.3 $2.45 5/15/2023265,900 shares $582,321.00 -20.0%N/A6.6 $2.19 4/30/2023332,500 shares $788,025.00 +7.7%N/A7.5 $2.37 4/15/2023308,600 shares $765,328.00 +52.6%N/A6.2 $2.48 3/31/2023202,300 shares $489,566.00 +43.6%N/A4.1 $2.42 3/15/2023140,900 shares $324,070.00 +17.9%N/A2.5 $2.30 2/28/2023119,500 shares $423,902.35 -42.5%N/A2.3 $3.55 2/15/2023207,900 shares $685,924.47 -32.3%N/A3.7 $3.30 1/31/2023307,200 shares $915,456.00 -17.6%N/A4.8 $2.98 1/15/2023372,900 shares $976,998.00 +0.7%N/A4.1 $2.62 12/30/2022370,400 shares $692,648.00 -8.6%N/A3.8 $1.87 12/15/2022405,300 shares $656,586.00 -7.8%N/A4.1 $1.62 11/30/2022439,700 shares $892,591.00 +6.1%N/A4 $2.03 11/15/2022414,300 shares $592,449.00 -39.7%N/A3.6 $1.43 10/31/2022687,300 shares $1.34 million -3.0%N/A6 $1.95 10/15/2022708,800 shares $886,567.04 +5.6%N/A6.6 $1.25 9/30/2022671,500 shares $859,520.00 -19.7%N/A7.7 $1.28 9/15/2022836,600 shares $1.24 million -8.8%N/A7.1 $1.48 8/31/2022917,200 shares $1.91 million +4.2%N/A8.4 $2.08The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him RNLX Short Interest - Frequently Asked Questions What is Renalytix's current short interest? Short interest is the volume of Renalytix shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 673,700 shares of RNLX short. Learn More on Renalytix's current short interest. Is Renalytix's short interest increasing or decreasing? Renalytix saw a decrease in short interest in the month of April. As of April 15th, there was short interest totaling 673,700 shares, a decrease of 15.3% from the previous total of 795,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Renalytix's short interest compare to its competitors? Here is how the short interest of companies compare to Renalytix: Ondas Holdings Inc. (2.70%), GAN Limited (1.11%), Research Frontiers Incorporated (1.39%), Edgio, Inc. (11.05%), LivePerson, Inc. (11.90%), Cutera, Inc. (40.21%), Phunware, Inc. (12.17%), LightPath Technologies, Inc. (0.26%), Comtech Telecommunications Corp. (9.59%), Marchex, Inc. (0.33%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Renalytix stock? Short selling RNLX is an investing strategy that aims to generate trading profit from Renalytix as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Renalytix? A short squeeze for Renalytix occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RNLX, which in turn drives the price of the stock up even further. How often is Renalytix's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RNLX, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Ondas Short Squeeze GAN Short Squeeze Research Frontiers Short Squeeze Edgio Short Squeeze LivePerson Short Squeeze Cutera Short Squeeze Phunware Short Squeeze LightPath Technologies Short Squeeze Comtech Telecommunications Short Squeeze Marchex Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RNLX) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold